Loading data
PASGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 23.28 m USD | 40.18 m USD | 61.42 m USD | — | — |
| Operating profit | -49.3 m USD | -70.4 m USD | -108.39 m USD | -138.39 m USD | -185.73 m USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -45.52 m USD | -64.77 m USD | -102.06 m USD | -136.13 m USD | -185.39 m USD |
| Basic earnings per share | -14.35 USD/share | -21.04 USD/share | -1.86 USD/share | -2.5 USD/share | -3.48 USD/share |
| Diluted earnings per share | -14.35 USD/share | -21.04 USD/share | -1.86 USD/share | -2.5 USD/share | -3.48 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.